Latest Stories
3 Reasons to Sell WAT and 1 Stock to Buy Instead
Waters Corporation trades at $386.11 per share and has stayed right on track with the overall market, gaining 10.4% over the last six months. At the same time, the S&P 500 has returned 13.4%.
Commerce (CMRC): Buy, Sell, or Hold Post Q3 Earnings?
Over the past six months, Commerce’s shares (currently trading at $4.64) have posted a disappointing 14.3% loss, well below the S&P 500’s 13.4% gain. This may have investors wondering how to approach the situation.
3 Reasons We’re Fans of Watts Water Technologies (WTS)
Watts Water Technologies trades at $267.30 per share and has stayed right on track with the overall market, gaining 9% over the last six months. At the same time, the S&P 500 has returned 13.4%.
3 Reasons CVS is Risky and 1 Stock to Buy Instead
CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to $78.44 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons VZ is Risky and 1 Stock to Buy Instead
Over the past six months, Verizon’s shares (currently trading at $40.24) have posted a disappointing 8.8% loss, well below the S&P 500’s 13.4% gain. This might have investors contemplating their next move.
Cadre (CDRE): Buy, Sell, or Hold Post Q3 Earnings?
Cadre has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.8%. The stock now trades at $43.11, marking a 23.1% gain. This performance may have investors wondering how to approach the situation.
3 Reasons to Avoid EPC and 1 Stock to Buy Instead
What a brutal six months it’s been for Edgewell Personal Care. The stock has dropped 37.2% and now trades at $16.43, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Sell LOCO and 1 Stock to Buy Instead
El Pollo Loco has been treading water for the past six months, recording a small return of 3.7% while holding steady at $11.33. The stock also fell short of the S&P 500’s 13.4% gain during that period.
3 Reasons to Sell TFC and 1 Stock to Buy Instead
Truist Financial trades at $47.70 and has moved in lockstep with the market. Its shares have returned 17.1% over the last six months while the S&P 500 has gained 13.4%.
3 Reasons to Avoid DOX and 1 Stock to Buy Instead
Over the last six months, Amdocs’s shares have sunk to $77.15, producing a disappointing 17.3% loss - a stark contrast to the S&P 500’s 13.4% gain. This may have investors wondering how to approach the situation.